Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression

TT van Sloten, S Sedaghat, MR Carnethon… - The lancet Diabetes & …, 2020 - thelancet.com
Adults with type 2 diabetes are at an increased risk of developing certain brain or mental
disorders, including stroke, dementia, and depression. Although these disorders are not …

Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases

CG Schalkwijk, CDA Stehouwer - Physiological reviews, 2020 - journals.physiology.org
The formation and accumulation of methylglyoxal (MGO), a highly reactive dicarbonyl
compound, has been implicated in the pathogenesis of type 2 diabetes, vascular …

Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences

CDA Stehouwer - Diabetes, 2018 - Am Diabetes Assoc
Microvascular and metabolic physiology are tightly linked. This Perspective reviews
evidence that 1) the relationship between hyperglycemia and microvascular dysfunction …

[HTML][HTML] Dietary sugars and endogenous formation of advanced glycation endproducts: emerging mechanisms of disease

M Aragno, R Mastrocola - Nutrients, 2017 - mdpi.com
The rapid increase in metabolic diseases, which occurred in the last three decades in both
industrialized and developing countries, has been related to the rise in sugar-added foods …

[HTML][HTML] Accumulation of advanced glycation end-products in the body and dietary habits

A Zawada, A Machowiak, AM Rychter, AE Ratajczak… - Nutrients, 2022 - mdpi.com
The formation of advanced glycation end-products (AGE) in tissues is a physiological
process; however, excessive production and storage are pathological and lead to …

Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes

NMJ Hanssen, J Westerink, JLJM Scheijen… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE Methylglyoxal (MGO) is a reactive dicarbonyl compound and a potential key
player in diabetic cardiovascular disease (CVD). Whether plasma MGO levels are …

[HTML][HTML] Dicarbonyl stress in diabetic vascular disease

B Stratmann - International Journal of Molecular Sciences, 2022 - mdpi.com
Late vascular complications play a prominent role in the diabetes-induced increase in
morbidity and mortality. Diabetes mellitus is recognised as a risk factor driving …

Role of vitamins in the metabolic syndrome and cardiovascular disease

A Aguilera-Méndez, D Boone-Villa… - … -European Journal of …, 2022 - Springer
The prevalence of metabolic syndrome and cardiovascular disease has increased and
continues to be the leading cause of mortality worldwide. The etiology of these diseases …

[HTML][HTML] Dicarbonyl stress in clinical obesity

J Masania, M Malczewska-Malec, U Razny… - Glycoconjugate …, 2016 - Springer
The glyoxalase system in the cytoplasm of cells provides the primary defence against
glycation by methylglyoxal catalysing its metabolism to D-lactate. Methylglyoxal is the …

A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and …

AR Alshanwani, H Hagar, S Shaheen… - European Journal of …, 2022 - Elsevier
Liver fibrosis is a common chronic hepatic disease. This study was done to examine the
effect of pyridoxamine against thioacetamide-induced hepatic fibrosis. Animals were divided …